DiaMedica Therapeutics
DMAC • NASDAQ • Stock Fundamentals
DiaMedica Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dietrich John Pauls, with a market cap of $294.2M.
Market Cap$294.2M
Employees19.0
CEODietrich John Pauls
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
DiaMedica Therapeutics FAQ
Common questions about DiaMedica Therapeutics
DiaMedica Therapeutics (DMAC) has a market capitalization of $294.2M and trades on NASDAQ.
DiaMedica Therapeutics has approximately 19 employees.